Femasys To Participate in Upcoming BTIG Biotechnology Conference
03 août 2022 08h00 HE
|
Femasys Inc.
ATLANTA, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys To Host Key Opinion Leader Event on FemBloc, a First-of-its-Kind Medical Solution for Permanent Birth Control and an Important Option for Women Post Overturn of Roe v. Wade
20 juil. 2022 07h00 HE
|
Femasys Inc.
ATLANTA, July 20, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys to Participate in the Women’s Health Panel Discussion Presented by Maxim Group LLC and hosted by M-Vest on Wednesday, July 13th at 11 a.m. ET
11 juil. 2022 08h30 HE
|
Femasys Inc.
ATLANTA, July 11, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. Announces Existing Board Member Charles Larsen as Chairperson of the Board
06 juil. 2022 08h00 HE
|
Femasys Inc.
ATLANTA, July 06, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. to Present at the LSX World Congress USA 2022
15 juin 2022 08h00 HE
|
Femasys Inc.
ATLANTA, June 15, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...
Femasys Inc. Announces Financial Results for the First Quarter Ended March 31, 2022
11 mai 2022 16h05 HE
|
Femasys Inc.
- Furthers advancement of much-needed minimally invasive technologies for underserved areas of women’s health with pending commercialization of products, FemCerv® and FemCath™ expected by year-end ...
Femasys Inc. to Participate in the M-Vest 2022 Virtual Growth Conference
25 mars 2022 08h00 HE
|
Femasys Inc.
ATLANTA, March 25, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include...
Femasys Inc. Announces Financial Results for the Year Ended December 31, 2021
24 mars 2022 16h05 HE
|
Femasys Inc.
-- Company builds out management team and continues to implement its clinical programs to advance much-needed technologies for women’s health -- ATLANTA, March 24, 2022 (GLOBE NEWSWIRE) -- Femasys...
Femasys Inc. Announces the Appointment of Dov Elefant to New Position of Chief Financial Officer
24 févr. 2022 08h00 HE
|
Femasys Inc.
-- Seasoned financial executive with 25 years of experience leading public and private biotech companies throughout various stages -- ATLANTA, Feb. 24, 2022 (GLOBE NEWSWIRE) -- Femasys Inc....
Femasys Inc. Announces the Appointment of Wendy Perrow, Transformational Biotech Entrepreneur, as New Board Member
20 janv. 2022 08h00 HE
|
Femasys Inc.
ATLANTA, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs worldwide by developing a suite of product candidates that include minimally...